CARISA GEYER: Open Payments
NPI 1972173714 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 29 payments from 8 companies in 2025. Trend: 2023 $428 · 2024 $480 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $140 |
| Astellas Pharma US Inc | 6 | $112 |
| Exeltis, USA Inc. | 6 | $88 |
| SHIELD THERAPEUTICS INC | 1 | $54 |
| Gilead Sciences, Inc. | 2 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Ethicon US, LLC | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: ZURZUVAE, Veozah, SLYND, ACCRUFER, Trodelvy, Qelbree, VISTASEAL, Mirena.
Industry payments across KY — which companies pay providers there.
